Association between hemochromatosis genotype and lead exposure among elderly men: the normative aging study.

Because body iron burden is inversely associated with lead absorption, genes associated with hemochromatosis may modify body lead burden. Our objective was to determine whether the C282Y and/or H63D hemochromatosis gene (HFE) is associated with body lead burden. Patella and tibia lead levels were measured by K X-ray fluorescence in subjects from the Normative Aging Study. DNA samples were genotyped for C282Y and H63D using polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP). A series of multivariate linear regression models were constructed with bone or blood lead as dependent variables; age, smoking, and education as independent variables; and C282Y or H63D as independent risk factors and/or effect modifiers. Of 730 subjects, 94 (13%) carried the C282Y variant and 183 (25%) carried the H63D variant. In the crude analysis, mean tibia, patella, and blood lead levels were consistently lower in carriers of either HFE variant compared with levels in subjects with wild-type genotypes. In multivariate analyses that adjusted for age, smoking, and education, having an HFE variant allele was an independent predictor of significantly lower patella lead levels (p < 0.05). These data suggest that HFE variants have altered kinetics of lead accumulation after exposure. Among elderly men, subjects with HFE variants had lower patella lead levels. These effects may be mediated by alterations in lead toxicokinetics via iron metabolic pathways regulated by the HFE gene product and body iron stores.

[1]  Howard Hu,et al.  Bone lead as a new biologic marker of lead dose: recent findings and implications for public health. , 1998, Environmental health perspectives.

[2]  R. Leggett,et al.  Blood lead concentrations in hereditary hemochromatosis. , 1994, The Journal of laboratory and clinical medicine.

[3]  Rosalind J Wright,et al.  Association between iron deficiency and low-level lead poisoning in an urban primary care clinic. , 1999, American journal of public health.

[4]  Goyer Ra,et al.  The influence of iron deficiency on tissue content and toxicity of ingested lead in the rat. , 1972 .

[5]  C. M. Smith,et al.  A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. , 1995, Environmental health perspectives.

[6]  B. No̸rgaard-Pedersen,et al.  A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations , 1999, Human mutation.

[7]  M. Vahter,et al.  Phlebotomy increases cadmium uptake in hemochromatosis. , 2000, Environmental health perspectives.

[8]  W. Stewart,et al.  Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. , 2000, Environmental health perspectives.

[9]  R. Baumgartner,et al.  Impact of HLA-H mutations on iron stores in healthy elderly men and women. , 1997, Blood cells, molecules & diseases.

[10]  J. Chisolm,et al.  Erythrocyte porphobilinogen synthase activity as an indicator of lead exposure in children. , 1985, Clinical chemistry.

[11]  ASHG report. Statement on informed consent for genetic research. The American Society of Human Genetics. , 1996, American journal of human genetics.

[12]  F. Collins,et al.  Hereditary hemochromatosis: gene discovery and its implications for population-based screening. , 1998, JAMA.

[13]  R. Goyer,et al.  The influence of iron deficiency on tissue content and toxicity of ingested lead in the rat. , 1972, The Journal of laboratory and clinical medicine.

[14]  J. Haddow,et al.  Hereditary haemochromatosis mutation frequencies in the general population , 1998, Journal of medical screening.

[15]  R. Wright.  The role of iron therapy in childhood plumbism. , 1999, Current opinion in pediatrics.

[16]  Howard Hu,et al.  Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. , 1998, Environmental health perspectives.

[17]  R. Desnick,et al.  The delta-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. , 1991, Environmental research.

[18]  M. O'Leary,et al.  Prevalence of Hereditary Hemochromatosis in 16 031 Primary Care Patients , 1998, Annals of Internal Medicine.

[19]  P. Fergelot,et al.  A candidate gene for hemochromatosis: frequency of the C282Y and H63D mutations , 1997, Human Genetics.

[20]  A. Onalaja,et al.  Genetic susceptibility to lead poisoning. , 2000, Environmental health perspectives.

[21]  H. Hu,et al.  The use of K X-ray fluorescence for measuring lead burden in epidemiological studies: high and low lead burdens and measurement uncertainty. , 1991, Environmental health perspectives.

[22]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[23]  J. Barton,et al.  Effects of iron on the absorption and retention of lead. , 1978, The Journal of laboratory and clinical medicine.

[24]  P S Gartside,et al.  Blood lead levels and dietary calcium intake in 1- to 11-year-old children: the Second National Health and Nutrition Examination Survey, 1976 to 1980. , 1986, Pediatrics.

[25]  C. Datz,et al.  Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: a protective role against iron deficiency? , 1998, Clinical chemistry.

[26]  W. Sly,et al.  Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Weiss,et al.  The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study. , 2001, Environmental health perspectives.

[28]  Alvaro N. A. Monteiro.  The Significance of the 187 G ( H 63 D ) Mutation in Hemochromatosis , 2006 .

[29]  A. Rotnitzky,et al.  Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The normative aging study. , 1996, American journal of epidemiology.

[30]  T. Cox,et al.  Haemochromatosis: an inherited metal and toxicity syndrome. , 1998, Current opinion in genetics & development.

[31]  P. Langenberg,et al.  Relationship between blood lead and dietary iron intake in preschool children. A cross-sectional study. , 1996, Annals of epidemiology.

[32]  D Simon,et al.  Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers. , 2000, Environmental health perspectives.

[33]  Albert Damon,et al.  The Normative Aging Study: An Interdisciplinary and Longitudinal Study of Health and Aging , 1972 .

[34]  Esin,et al.  HFE mutations in patients with hereditary haemochromatosis in Sweden , 1998, Journal of internal medicine.

[35]  P. Shrout,et al.  Determinants of elevated blood lead during pregnancy in a population surrounding a lead smelter in Kosovo, Yugoslavia , 1990, Environmental health perspectives.

[36]  E. Beutler.  The significance of the 187G (H63D) mutation in hemochromatosis. , 1997, American journal of human genetics.

[37]  L M Kopelman,et al.  Informed consent for genetic research on stored tissue samples. , 1995, JAMA.

[38]  L. Goldman,et al.  Iron deficiency associated with higher blood lead in children living in contaminated environments. , 2001, Environmental health perspectives.

[39]  M. Nathanson,et al.  Regulation of intestinal iron absorption and mucosal iron kinetics in hereditary hemochromatosis. , 1991, The Journal of laboratory and clinical medicine.